Low‐dose naltrexone in Hailey–Hailey disease: the importance of dosing (Abstract)

The LDN Conference 2021: 4th - 6th June 2021

Up to 29 CME Credits Available + Sponsor, Exhibitor and Advertiser Opportunities.  [More Details]

Low‐dose naltrexone in Hailey–Hailey disease: the importance of dosing

Br J Dermatol
July 2020
https://www.researchgate.net/publication/339716445_Low-dose_naltrexone_in_Hailey-Hailey_disease_the_importance_of_dosing

We read with great interest the study by Jasans‐Barceló et al. where they report the response of low‐dose naltrexone in 8 patients of HHD.1 One interesting observation we made in the article was the response of one patient to the standard higher dose (50 mg) of naltrexone. Two previous studies that used the 50 mg dose in HHD patients (3 patients total) had failed to show any positive response.